** Shares of Atomo Diagnostics AT1.AX rise as much as 13.5% to A$0.042, their highest level since January 5
** Stock logs its biggest intraday pct gain since January 2
** The medical device firm secures purchase order for A$502,000 ($335,386.20) worth of HIV self-tests
** Adds that supply order is for an African country
** Stock set for a third consecutive session of gains, if current momentum persists
** Stock up nearly 90% in 2025
($1 = 1.4968 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.